Figure 1: CD133 in GBMs is not predictive of patient survival. Kaplan-Meier survival plot for floiblastoma patients with differential tumor CD133 expression calculated by TGCA (A) and REMBRANT (B) database. The log-rank P-value for significance of difference of survival between group was calculated as>0.05 in all cases.